If you have asthma that is not well controlled, you have probably seen the adverts: a short form,
a promise that researchers in your area are looking for people like you, and a request for your
phone number. Asthma is one of the most heavily recruited conditions in US clinical research, and
the recruitment industry around it is substantial.
That does not make it illegitimate. Asthma trials are real, they are common, and for some people
joining one is a reasonable decision. But the adverts are marketing, and they are not where the
decision should be made. This article covers why asthma is recruited so heavily, what joining
typically involves, and how to check that a specific study is real before you share anything.
It is information, not medical advice. MediVara does not screen, endorse or recommend
any trial or recruitment service.
Why asthma trials recruit so aggressively
Three things make asthma unusually attractive to researchers, and they explain the volume of
advertising.
The population is large. Current asthma affects around 7.7% of the US
population, so a great many people are potentially eligible for something.
A lot of it is not well controlled. Half of children with current asthma had
uncontrolled asthma, and close to four in ten adults with asthma reported an attack in 2021. Poor
control is precisely what new treatments are trying to address, so trials actively seek people whose
current regimen is not working well.
It is measurable. Lung function can be quantified, symptoms and rescue-inhaler
use can be counted, and exacerbations are countable events. Conditions that produce clean numbers
are easier to study, which means more studies get run.
The result is genuine demand for participants — and a recruitment industry built to meet
it. Both things are true at once.
What an asthma trial usually involves
Specifics vary enormously by study, and the only reliable source is the protocol for the study in
front of you. In general terms, expect:
- A screening visit before enrolment, typically including lung-function testing.
Many people are screened and not enrolled. - A run-in period in some studies, during which your existing treatment is
standardised before anything changes. - Regular visits — often more frequent than your ordinary asthma care.
- Spirometry at most visits.
- A daily diary of symptoms and rescue-inhaler use.
- Rules about your other medication, which is the part most worth understanding
in detail before agreeing.
That last point deserves emphasis. Ask exactly what happens to your current treatment, whether
any of it is paused or replaced, and what you are to do if your asthma worsens during the study.
A trial should have a defined answer for that, and you should know it before you enrol.
The placebo question, specifically for asthma
This is the question people most want answered and most hesitate to ask.
Ask two things, separately. Is there a placebo group? And what does that group
receive? In many trials for conditions where withholding treatment would be unsafe, the
comparison group receives standard care with placebo added to it, rather than placebo instead of
treatment. That is a materially different proposition from going untreated, and the answer should
be stated plainly in the consent discussion.
Also ask what the rules are for using your rescue inhaler during the study, and what triggers the
study team to take you out of it if your asthma deteriorates.
Checking that a study is real
Many asthma trials recruit through third-party websites and ad campaigns. Some are run by
legitimate recruitment firms working for a sponsor. A polished page tells you nothing either way,
and the site is not the study.
- Ask for the NCT number. Every registered study has one. A legitimate recruiter
can provide it. - Look it up on ClinicalTrials.gov
yourself, by typing the address rather than following a link you were sent. - Compare the advert against the registry record — condition, phase,
eligibility criteria, recruiting status, sponsor and listed locations. - Check a site near you is genuinely recruiting.
- Ask what happens to your data if you are screened out. A recruitment form is a
disclosure of health information. You are entitled to know whether it is retained, shared or used
for marketing.
Treat these as warning signs: no NCT number available on request, guaranteed acceptance, any
request for payment to participate, pressure to decide immediately, or a claim that the study will
cure your asthma. Legitimate studies do not charge participants, and research does not make
guarantees.
Our general guide to how clinical trials work, including consent, eligibility and IRB oversight,
covers the verification process in more detail.
Questions specific to an asthma study
- What is being tested, and what phase is the study?
- What happens to my current controller and reliever medication?
- Is there a placebo arm, and what does that arm receive?
- What are the rules for rescue-inhaler use during the study?
- What happens if my asthma gets worse — who do I contact, at any hour?
- How many visits, how long is each, and over what total period?
- Will I have spirometry, and will I be told my results?
- Who pays for what? Research procedures are commonly covered by the sponsor, but routine care
may still be billed. - Are travel and time reimbursed?
- What happens at the end — can I continue the treatment if it helped?
- Will my usual asthma clinician be informed that I am enrolled?
That last question is easy to skip and worth asking. Someone is managing your asthma; a study is
a significant change to it.
Deciding, honestly
The reasonable reasons to join are access to something not otherwise available, closer monitoring
than routine care usually provides, and contributing to knowledge that helps other people with
asthma later. All three are real.
Against that: the treatment may not work, you may be in the comparison arm, there may be unknown
side effects, and the visit schedule is usually more demanding than ordinary care. Declining a trial
is a completely reasonable decision, and being screened out is common and not a judgement about you.
Before enrolling, discuss it with the clinician who manages your asthma. They
know your control history, your current regimen and how a study’s medication rules would interact
with it — none of which a recruitment form can see.
Before you look at trials at all
If the reason you are considering a study is that your asthma is not well controlled, there are
two things worth ruling out first, because both are common and both are fixable.
Inhaler technique. More than 8 in 10 US patients with obstructive lung disease
make at least one technique error, and technique decays over time even after correct teaching. If a
share of every dose is not reaching your lungs, the medication will look less effective than it is.
This is worth checking with a pharmacist
before concluding that your treatment has failed.
Whether your plan has been reviewed recently. Asthma guidance has changed
meaningfully in recent years. A regimen that has not been revisited in a long time may not reflect
current practice, and what “controlled” should look like
is a reasonable thing to raise at your next appointment.
A clinical trial is a legitimate option. It should not be the first thing tried when simpler
explanations have not been ruled out.
Sources
- ClinicalTrials.gov — Learn About Studies
- ClinicalTrials.gov — Glossary Terms
- CDC — Most Recent Asthma Data
- Inhalation Technique Errors with Metered-Dose Inhalers: A Systematic Review and Meta-Analysis of U.S. Studies
MediVara publishes health journalism. This article is not medical advice, is not reviewed by
a licensed clinician, and MediVara does not screen, endorse or recommend any clinical trial or
recruitment service. Decisions about trial participation and about asthma treatment belong with a
qualified healthcare professional.
Frequently asked questions
Are asthma clinical trials legitimate?
Asthma trials are real and common, and asthma is one of the most heavily recruited conditions in US clinical research. That recruitment volume is driven by genuine factors: a large population, a high proportion of poorly controlled disease, and outcomes that are easy to measure. But an advert is marketing, and the site running it is not the study. Verify any specific study on ClinicalTrials.gov using its NCT number before sharing your details.
Will I be given a placebo in an asthma trial?
It depends on the study design, and you should ask two separate questions: whether there is a placebo group, and what that group actually receives. In many trials for conditions where withholding treatment would be unsafe, the comparison group receives standard care with placebo added to it rather than placebo instead of treatment. Also ask what the rules are for rescue-inhaler use and what happens if your asthma worsens during the study.
Does it cost money to join an asthma trial?
Legitimate studies do not charge participants to take part, and any request for payment is a serious warning sign. Research procedures are commonly covered by the sponsor, but routine care costs may still be billed to you or your insurer, so ask specifically who pays for what before enrolling.
What happens to my current asthma medication during a trial?
This is the part most worth understanding in detail before agreeing. Ask exactly what happens to your current controller and reliever, whether any of it is paused or replaced, what the rules are for rescue-inhaler use, and what you should do if your asthma worsens. A study should have a defined answer for each, and you should know it before you enrol.
Should I try anything else before looking at trials?
If the reason you are considering a study is poor control, two common and fixable things are worth ruling out first. The first is inhaler technique: more than 8 in 10 US patients with obstructive lung disease make at least one technique error, and technique decays over time even after correct teaching. The second is whether your treatment plan has been reviewed recently, since asthma guidance has changed meaningfully in recent years.
Leave a Reply